Lawsuit Overview
March 19, 2022 - An amended complaint was filed. April 19, 2021 - An investor in shares of Emergent BioSolutions Inc (NYSE: EBS) filed a lawsuit in the U.S. District Court for the District of Maryland over alleged violations of Federal Securities Laws by Emergent BioSolutions Inc in connection with certain allegedly false and misleading statements made between July 6, 2020 and March 3...
You must register (for free) or login to view the entire case.